Tejara Capital Ltd’s Arcutis Biotherapeutics Inc Position
Does Tejara Capital Ltd own Arcutis Biotherapeutics Inc (ARQT)? Yes — 166.2K shares worth $4M (+1.29% of its 13F portfolio) as of Q1 2026, down from 520.5K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
166.2K
% of Portfolio
+1.29%
Quarters Held
13
currently held
Position History ARQT
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 166.2K | $4M | +1.29% |
| Q3 2025 | 520.5K | $10M | +5.12% |
| Q2 2025 | 873.4K | $12M | +5.68% |
| Q1 2025 | 846.2K | $13M | +5.11% |
| Q4 2024 | 886.8K | $12M | +8.09% |
| Q3 2024 | 1.17M | $11M | +5.16% |
| Q2 2024 | 1.34M | $12M | +4.54% |
| Q1 2024 | 940.5K | $9M | +3.42% |
| Q4 2023 | 1.11M | $4M | +1.50% |
| Q3 2023 | 309.2K | $2M | +0.93% |
| Q2 2023 | 164.2K | $2M | +0.77% |
| Q1 2023 | 98.0K | $1M | +0.55% |
| Q4 2022 | 58.0K | $858,400 | +0.49% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Tejara Capital Ltd’s full portfolio or all institutional holders of ARQT.